Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_assertion type Assertion NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_head.
- NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_assertion description "[Promoter hypermethylation of MGMT is commonly used to predict low expression levels of MGMT in gliomas, despite observed discordance between promoter methylation and protein levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_provenance.
- NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_assertion evidence source_evidence_literature NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_provenance.
- NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_assertion SIO_000772 24568970 NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_provenance.
- NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_assertion wasDerivedFrom befree-2016 NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_provenance.
- NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_assertion wasGeneratedBy ECO_0000203 NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_provenance.